Skip to content

Clinical trials

Phase 1/2 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 1/2 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20093
20103
20112
20123
20132
20142
20162
20181
20191
20202
20211
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status5
Active, not recruiting3
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Santen Inc.3
Allergan2
Bausch & Lomb Incorporated2
AbbVie1
Alcon Research1
Altheos, Inc.1
American Society Of Thermalism And Climatology Inc1
Catholic University of the Sacred Heart1
Danube Pharmaceuticals, Inc.1
EyeD Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension30
Glaucoma, Open-Angle20
Glaucoma18
Cataract2
Lens Diseases1

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.